Submit Animal Toxicity Study Report: CDSCO Panel Tells Lupin on Parkinsonism FDC drug Written By Dr. Divya Colin9 Feb 2024 6:00 PM ISTNew Delhi: Noting that the proposed dose is higher than the approved dose, the Subject Expert Committee (SEC) functional under the Central Drug...
Conduct India-specific Trial: CDSCO Panel Tells Roche on Satralizumab to Treat neuromyelitisoptica spectrum disorders Written By Dr. Divya Colin8 Feb 2024 6:00 PM ISTNew Delhi: With an aim to establish the safety and efficacy of the Monoclonal Antibody Satralizumab in Indian patients, the Subject Expert Committee...
NPPA fixes price for various FDCs having Sitagliptin, Linagliptin Written By Ruchika Sharma7 Feb 2024 6:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs...
MSD NOT involved in Poonam Pandey fake death stunt: Makers of Gardasil clarify, cut ties with agency involved in controversy Farhat Nasim7 Feb 2024 4:50 PM ISTNew Delhi: MSD, the Indian affiliate of the US pharmaceutical giant Merck has clarified that it is not associated with actor and model Poonam Pandey’s...
Synokem gets CDSCO Panel nod to study FDC Torsemide plus Eplerenone film coated tablet Written By Dr. Divya Colin6 Feb 2024 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) report of the fixed-dose combination (FDC) Torsemide IP 10mg/ 20mg plus Eplerenone IP 25mg/25mg...
CDSCO Panel grants Intas Package Insert update for Pegfilgrastim solution for injection 6mg/0.6mL vial and PFS Written By Dr. Divya Colin5 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Center Drug Standard Control Organisation (CDSCO) has approved drug major Intas...
Windlass Biotech gets CDSCO Panel Nod To Manufacture, Market Ezetimibe plus Atorvastatin Calcium tablet Written By Dr. Divya Colin4 Feb 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Windlas Biotech, the Subject Expert Committee (SEC) functional under the Central...
Add geographically distributed Govt sites: CDSCO Panel tells Dr Reddy's on antirheumatic drug Abatacept study Written By Dr. Divya Colin3 Feb 2024 6:00 PM ISTNew Delhi: The drug major Dr Redyy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Novartis Gets CDSCO Panel Nod to Study XXB750 in Patients With Heart Failure Written By Dr. Divya Colin2 Feb 2024 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharma Gets CDSCO Panel Nod to Study anti-cancer Drug Lipid Based Cabazitaxel Written By Dr. Divya Colin1 Feb 2024 6:00 PM ISTNew Delhi: Citing that the firm should include an adequate number of government hospital trial sites, the Subject Expert Committee (SEC) functional...
Novo Nordisk Gets CDSCO Panel conditional nod to study Insulin icodec Written By Dr. Divya Colin31 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novo Nordisk has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharma gets CDSCO Panel Nod To study Leuprolide acetate for depot suspension Written By Dr. Divya Colin30 Jan 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
